Piccini, J., Goodman, S., Levitan, B., Yuan, Z., Hankey, G. J., Singer, D. E., … Patel, M. R. (2016). Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL (Vol. 37, pp. 500–500). Rome, ITALY: OXFORD UNIV PRESS.

Piccini, J., S. Goodman, B. Levitan, Z. Yuan, G. J. Hankey, D. E. Singer, R. Becker, et al. “Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation.” In EUROPEAN HEART JOURNAL, 37:500–500. OXFORD UNIV PRESS, 2016.

Piccini J, Goodman S, Levitan B, Yuan Z, Hankey GJ, Singer DE, et al. Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2016. p. 500–500.

Piccini, J., et al. “Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation.” EUROPEAN HEART JOURNAL, vol. 37, OXFORD UNIV PRESS, 2016, pp. 500–500.

Piccini J, Goodman S, Levitan B, Yuan Z, Hankey GJ, Singer DE, Becker R, Breithardt G, Berkowitz S, Halperin J, Nessel C, Hacke W, Mahaffey KW, Fox KAA, Patel MR. Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2016. p. 500–500.